{"id":"W2791191075","doi":"10.1200/jco.2018.36.5_suppl.196","title":"Time to first-line (1L) therapy discontinuation in metastatic melanoma (MM).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Click Chemistry and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Discontinuation; Medicine; Pembrolizumab; Nivolumab; Internal medicine; Dabrafenib; Metastatic melanoma; Oncology; Pediatrics; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00154899,0.0001118984,0.000697688,0.00004630021,0.00004466471,0.00001210222,0.0003107049,0.0001969126,0.004473876],"category_scores_gemma":[0.002129611,0.00008741784,0.0002127423,0.0001585691,0.0001641136,0.00008263822,0.00004552914,0.0004839063,0.0003534422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007825602,"about_ca_system_score_gemma":0.0002854419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008281356,"about_ca_topic_score_gemma":0.00007672143,"domain_scores_codex":[0.9975759,0.00007648158,0.001799481,0.0001800944,0.0001882872,0.0001797387],"domain_scores_gemma":[0.9964996,0.001860798,0.0009697418,0.0002257973,0.000229798,0.0002142669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005007902,0.009087996,0.01445667,0.00004179851,0.000543374,0.0002043238,0.0008428822,0.0001823496,0.1033371,0.0001917555,0.03519591,0.8309079],"study_design_scores_gemma":[0.006795693,0.003395523,0.01117495,0.0001149342,0.00009717717,0.000103622,0.0001211152,0.0006724111,0.05207222,0.002021058,0.9231706,0.0002606701],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735258,0.00006772043,0.000155612,0.01132583,0.0001218635,0.00006448755,0.000007468728,0.000009067657,0.01472215],"genre_scores_gemma":[0.9923198,0.0001180345,0.001703143,0.0009658259,0.001765722,0.00001202395,0.000006545941,0.00001314815,0.003095742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8879747,"threshold_uncertainty_score":0.9964362,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1259341740086885,"score_gpt":0.4620217195089515,"score_spread":0.336087545500263,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}